Total Payments
$1,428
2024 Payments
$46.13
Companies
19
Transactions
46
Medicare Patients
2,778
Medicare Billing
$360,956
Payment Breakdown by Category
Food & Beverage$928.59 (65.0%)
Travel$482.96 (33.8%)
Education$16.74 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $928.59 | 42 | 65.0% |
| Travel and Lodging | $482.96 | 3 | 33.8% |
| Education | $16.74 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $560.75 | 5 | $0 (2017) |
| ABBVIE INC. | $185.07 | 9 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $148.48 | 1 | $0 (2019) |
| Allergan Inc. | $85.38 | 5 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $74.76 | 4 | $0 (2017) |
| Janssen Biotech, Inc. | $60.38 | 4 | $0 (2018) |
| Shire North American Group Inc | $57.18 | 3 | $0 (2017) |
| PFIZER INC. | $50.27 | 3 | $0 (2019) |
| Ironwood Pharmaceuticals, Inc | $39.86 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $23.63 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.13 | 2 | E.R. Squibb & Sons, L.L.C. ($23.63) |
| 2023 | $58.20 | 3 | ABBVIE INC. ($58.20) |
| 2022 | $103.38 | 5 | ABBVIE INC. ($43.82) |
| 2019 | $277.35 | 8 | W. L. Gore & Associates, Inc. ($148.48) |
| 2018 | $111.05 | 6 | Allergan Inc. ($37.66) |
| 2017 | $832.18 | 22 | Covidien LP ($560.75) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Neuroscience | ||||||
| 01/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2023 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/05/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: GI | ||||||
| 05/25/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: IMMUNOLOGY | ||||||
| 04/06/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Neuroscience | ||||||
| 03/31/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2022 | Enterra Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| 12/11/2019 | PFIZER INC. | XELJANZ (Drug) | Education | In-kind items and services | $16.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/09/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/04/2019 | W. L. Gore & Associates, Inc. | EXCLUDER AAA Endoprosthesis (Device) | Food and Beverage | In-kind items and services | $148.48 | General |
| Category: Devices | ||||||
| 07/24/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Lower GI | ||||||
| 04/09/2019 | Olympus America Inc. | Olympus Capital Accessories (Device) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: GI & Respiratory Products | ||||||
| 02/20/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Immunology | ||||||
| 01/17/2019 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2018 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI, REMICADE | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Immunology | ||||||
| 07/25/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Immunology | ||||||
| 06/20/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2018 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 02/08/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Anemia | ||||||
| 12/21/2017 | Braintree Laboratories, Inc. | SUPREP (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 675 | 719 | $656,318 | $97,623 |
| 2022 | 12 | 653 | 691 | $603,386 | $87,630 |
| 2021 | 14 | 731 | 797 | $576,847 | $89,682 |
| 2020 | 14 | 719 | 770 | $635,035 | $86,021 |
Total Patients
2,778
Total Services
2,977
Medicare Billing
$360,956
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 178 | 179 | $212,294 | $22,635 | 10.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 86 | 86 | $115,240 | $18,227 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 108 | $42,984 | $9,872 | 23.0% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 23 | 23 | $26,795 | $9,619 | 35.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 42 | 44 | $42,504 | $7,485 | 17.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 86 | $88,924 | $7,299 | 8.2% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 22 | 22 | $13,574 | $4,865 | 35.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 24 | 24 | $23,184 | $4,257 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $19,692 | $4,211 | 21.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 31 | 32 | $25,920 | $2,776 | 10.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 22 | 23 | $24,495 | $2,768 | 11.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $11,592 | $1,446 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $5,400 | $1,202 | 22.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 24 | $3,720 | $961.20 | 25.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 151 | 151 | $179,091 | $18,990 | 10.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 90 | 91 | $121,922 | $18,526 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 123 | $45,766 | $11,913 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $32,361 | $7,819 | 24.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 80 | 81 | $83,740 | $6,908 | 8.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 38 | 38 | $36,704 | $6,844 | 18.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 27 | 27 | $28,754 | $3,500 | 12.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 17 | $16,421 | $3,192 | 19.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 36 | 37 | $29,480 | $2,936 | 10.0% |
| 91122 | Study of rectum sensitivity and function | Office | 2022 | 12 | 12 | $7,403 | $2,837 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 40 | $10,063 | $2,638 | 26.2% |
About Dr. Bryan Kavanaugh, MD
Dr. Bryan Kavanaugh, MD is a Gastroenterology healthcare provider based in Colorado Springs, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346452273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Kavanaugh, MD has received a total of $1,428 in payments from pharmaceutical and medical device companies, with $46.13 received in 2024. These payments were reported across 46 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($928.59).
As a Medicare-enrolled provider, Kavanaugh has provided services to 2,778 Medicare beneficiaries, totaling 2,977 services with total Medicare billing of $360,956. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Colorado Springs, CO
- Active Since 05/04/2007
- Last Updated 07/26/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346452273
Products in Payments
- Smart Pill (Device) $495.32
- EXCLUDER AAA Endoprosthesis (Device) $148.48
- RINVOQ (Biological) $86.93
- PillCam (Device) $65.43
- LINZESS (Drug) $61.40
- STELARA (Biological) $60.38
- GATTEX (Drug) $57.18
- Humira (Biological) $48.50
- VIBERZI (Drug) $41.68
- ZEPOSIA (Drug) $40.43
- XIFAXAN (Drug) $38.89
- CREON (Drug) $37.59
- XELJANZ (Drug) $36.05
- RELISTOR ORAL (Drug) $23.93
- Linzess (Drug) $22.16
- OCA (Drug) $18.16
- CLENPIQ (Drug) $17.41
- Entyvio (Biological) $17.32
- INFLECTRA (Biological) $14.22
- Olympus Capital Accessories (Device) $14.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Colorado Springs
Dr. Douglas Adler, M.d, M.D
Gastroenterology — Payments: $1.0M
Gastroenterology $1.0M
Mr. Bhaktasharan Patel, Md, MD
Gastroenterology — Payments: $333,873
Gastroenterology $333,873
Dr. Lukasz Kowalczyk, M.d, M.D
Gastroenterology — Payments: $45,278
Gastroenterology $45,278
Thomas Meister, Md, MD
Gastroenterology — Payments: $17,557
Gastroenterology $17,557
Dr. Nicholas Costrini, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $9,329
Gastroenterology $9,329
Kem Hor, M.d, M.D
Gastroenterology — Payments: $6,030
Gastroenterology $6,030